CELGENE CORPORATION for CELGENE CORPORATION
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Issues relating to Patent Reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALANNA TEMME | — |
Health Issues HCR
HR 985, FAST Generics Act, provisions regarding REMS. H.R. 1730, Cancer Drug Parity Act, regarding all provisions. S. 741, Cancer Drug Parity Act,regarding all provisions. H.R. 2279, Safe Step Act, issues relating to Step Therapy / Fail First. HR 965 / S. 340, CREATES Act, provisions regarding REMS. Reimbursement for and patient access to Chimeric Antigen Receptor (CAR) T-cell therapies. Issues relating to Medicare Reimbursement and Medicare Part D / Part B.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG CHESMORE | — |
| HELEN FITZPATRICK New | — |
| PATRICK GLIHA | — |
| STEPHEN RUBRIGHT | — |
| MATTHEW SCHUMAKER | — |
| ALANNA TEMME | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.